| 1 |
Kanegaye JT, Wilder MS, Molkara D, et a1. Recognition of a Kawasaki disease shock syndrome [J]. Pediatrics, 2009, 123(5): 783-789.
|
| 2 |
蒋道菊，黄萍，张丽，等. 川崎病休克综合征的研究进展 [J]. 中华儿科杂志, 2016, 54(12): 961-963.
|
| 3 |
Natterer J, Perez MH, Di Bernardo S. Capillary leak leading to shock in Kawasaki disease without myocardial dysfunction [J]. Cardiol Young, 2012, 22(3): 349-352.
|
| 4 |
Park SJ, Pai KS, Ji HK, et al. What dose of intravenous immunoglobulin should be administered in Kawasaki disease with suspected systemic capillary leak syndrome? [J]. Eur J Pediatr, 2012, 171(1): 203-204.
|
| 5 |
仇慧仙，薛超超，陈其，等. 川崎病休克综合征的临床特点及危险因素分析 [J]. 中华危重症医学杂志, 2015, 8(4): 230-234.
|
| 6 |
Nagata S, Yamashiro Y, Ohtsuka Y, et al. Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease [J]. Immunology, 2009, 128(4): 511-520.
|
| 7 |
张明明，石琳，李晓惠，等. 川崎休克综合征11例临床分析 [J]. 中国临床医生杂志，2017, 45(9): 98-100.
|
| 8 |
İşgüder R, Doksöz Ö, Bağ Ö, et al. Kawasaki disease shock syndrome: a severe form of Kawasaki disease [J]. Turk J Pediatr, 2013, 55(3): 319-321.
|
| 9 |
Schuster JE, Palac HL, Innocentini N, et al. Hyponatremia is a feature of Kawasaki disease shock syndrome: A case-control study [J]. J Pediatric Infect Dis Soc, 2017, 6(4): 386-388.
|
| 10 |
单鸣凤，梅小丽，周凯，等. 儿童川崎病休克综合征的临床特点及相关因素 [J]. 中华实用儿科临床杂志, 2018, 33(9): 673-786.
|
| 11 |
Gámezgonzález LB, Murata C, Muñozramírez M, et al. Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children [J]. Eur J Pediatr, 2013, 172(3): 337-342.
|
| 12 |
Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council Association [J]. Pediatrics, 2004, 114(6): 1708-1733.
|